Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1

Davide Gabellini, Giuseppe D'Antona, Maurizio Moggio, Alessandro Prelle, Chiara Zecca, Raffaella Adami, Barbara Angeletti, Patrizia Ciscato, Maria Antonietta Pellegrino, Roberto Bottinelli, Michael R. Green, Rossella Tupler

Research output: Contribution to journalArticle

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene1,2. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing5-7. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.

Original languageEnglish
Pages (from-to)973-977
Number of pages5
JournalNature
Volume439
Issue number7079
DOIs
Publication statusPublished - Feb 23 2006

Fingerprint

Facioscapulohumeral Muscular Dystrophy
Transgenic Mice
Skeletal Muscle
RNA Precursors
Alternative Splicing
Genes
Muscular Dystrophies
Nuclear Proteins
Chromosomes
Muscles
Messenger RNA
Mutation

ASJC Scopus subject areas

  • General

Cite this

Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., ... Tupler, R. (2006). Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature, 439(7079), 973-977. https://doi.org/10.1038/nature04422

Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. / Gabellini, Davide; D'Antona, Giuseppe; Moggio, Maurizio; Prelle, Alessandro; Zecca, Chiara; Adami, Raffaella; Angeletti, Barbara; Ciscato, Patrizia; Pellegrino, Maria Antonietta; Bottinelli, Roberto; Green, Michael R.; Tupler, Rossella.

In: Nature, Vol. 439, No. 7079, 23.02.2006, p. 973-977.

Research output: Contribution to journalArticle

Gabellini, D, D'Antona, G, Moggio, M, Prelle, A, Zecca, C, Adami, R, Angeletti, B, Ciscato, P, Pellegrino, MA, Bottinelli, R, Green, MR & Tupler, R 2006, 'Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1', Nature, vol. 439, no. 7079, pp. 973-977. https://doi.org/10.1038/nature04422
Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature. 2006 Feb 23;439(7079):973-977. https://doi.org/10.1038/nature04422
Gabellini, Davide ; D'Antona, Giuseppe ; Moggio, Maurizio ; Prelle, Alessandro ; Zecca, Chiara ; Adami, Raffaella ; Angeletti, Barbara ; Ciscato, Patrizia ; Pellegrino, Maria Antonietta ; Bottinelli, Roberto ; Green, Michael R. ; Tupler, Rossella. / Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. In: Nature. 2006 ; Vol. 439, No. 7079. pp. 973-977.
@article{ef20832518e040d9b6d611d6218c1bb0,
title = "Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1",
abstract = "Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene1,2. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing5-7. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.",
author = "Davide Gabellini and Giuseppe D'Antona and Maurizio Moggio and Alessandro Prelle and Chiara Zecca and Raffaella Adami and Barbara Angeletti and Patrizia Ciscato and Pellegrino, {Maria Antonietta} and Roberto Bottinelli and Green, {Michael R.} and Rossella Tupler",
year = "2006",
month = "2",
day = "23",
doi = "10.1038/nature04422",
language = "English",
volume = "439",
pages = "973--977",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7079",

}

TY - JOUR

T1 - Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1

AU - Gabellini, Davide

AU - D'Antona, Giuseppe

AU - Moggio, Maurizio

AU - Prelle, Alessandro

AU - Zecca, Chiara

AU - Adami, Raffaella

AU - Angeletti, Barbara

AU - Ciscato, Patrizia

AU - Pellegrino, Maria Antonietta

AU - Bottinelli, Roberto

AU - Green, Michael R.

AU - Tupler, Rossella

PY - 2006/2/23

Y1 - 2006/2/23

N2 - Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene1,2. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing5-7. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.

AB - Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder that is not due to a classical mutation within a protein-coding gene1,2. Instead, almost all FSHD patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed D4Z4, located on chromosome 4q35 (ref. 3). D4Z4 contains a transcriptional silencer whose deletion leads to inappropriate overexpression in FSHD skeletal muscle of 4q35 genes located upstream of D4Z4 (ref. 4). To identify the gene responsible for FSHD pathogenesis, we generated transgenic mice selectively overexpressing in skeletal muscle the 4q35 genes FRG1, FRG2 or ANT1. We find that FRG1 transgenic mice develop a muscular dystrophy with features characteristic of the human disease; by contrast, FRG2 and ANT1 transgenic mice seem normal. FRG1 is a nuclear protein and several lines of evidence suggest it is involved in pre-messenger RNA splicing5-7. We find that in muscle of FRG1 transgenic mice and FSHD patients, specific pre-mRNAs undergo aberrant alternative splicing. Collectively, our results suggest that FSHD results from inappropriate overexpression of FRG1 in skeletal muscle, which leads to abnormal alternative splicing of specific pre-mRNAs.

UR - http://www.scopus.com/inward/record.url?scp=33644522383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644522383&partnerID=8YFLogxK

U2 - 10.1038/nature04422

DO - 10.1038/nature04422

M3 - Article

C2 - 16341202

AN - SCOPUS:33644522383

VL - 439

SP - 973

EP - 977

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7079

ER -